EDGAR Filing Documents for 0001047469-11-001901

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-11-001901

Filing Date

2011-03-09

Accepted

2011-03-09 15:45:16

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2202475z10-k.htm	10-K	1278506
2	EXHIBIT 10.53	a2202475zex-10_53.htm	EX-10.53	173103
3	EX10.54	a2202475zex-10_54.htm	EX-10.54	19798
4	EX-21.0	a2202475zex-21_0.htm	EX-21.0	3432
5	EX-23.1	a2202475zex-23_1.htm	EX-23.1	2607
6	EX-31.1	a2202475zex-31_1.htm	EX-31.1	8709
7	EX-31.2	a2202475zex-31_2.htm	EX-31.2	8716
8	EX-32	a2202475zex-32.htm	EX-32	7067
9	G64203.JPG	g64203.jpg	GRAPHIC	67930
10	G157274.JPG	g157274.jpg	GRAPHIC	39924
	Complete submission text file	0001047469-11-001901.txt		1651999

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725

Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)